Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Treco Douglas A Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Treco Douglas A (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 13,000 options to buy @ $62.59, valued at $813.7k
04/04/2023 4 Treco Douglas A (CEO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 800,000 options to buy @ $0
Granted 100,000 restricted stock units @ $0
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2020 4 Treco Douglas A (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 9,367 options to buy @ $16, valued at $149.9k
06/15/2020 4 Treco Douglas A (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 30,000 options to buy @ $59.7, valued at $1.8M
04/03/2020 4 Treco Douglas A (President and CEO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 234,707 shares @ $48, valued at $11.3M
Disposed/sold 139,371 options to buy @ $2.87, valued at $400k
Disposed/sold 241,460 options to buy @ $2.87, valued at $693k
Disposed/sold 164,285 options to buy @ $5.6, valued at $920k
Disposed/sold 225,000 options to buy @ $16.64, valued at $3.7M
Disposed/sold 125,000 options to buy @ $7.33, valued at $916.3k
Disposed/sold 311,000 options to buy @ $21, valued at $6.5M
Disposed/sold 20,833 restricted stock units @ $0
02/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2018 4 Treco Douglas A (President and CEO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Granted 125,000 options to buy @ $7.33, valued at $916.3k
Granted 62,500 restricted stock units @ $0
02/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy